跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
ELYXYB
Authorized
STANDARD
ELYXYB
SCILEX PHARMACEUTICALS INC.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
cb10717f21260705
Company
SCILEX PHARMACEUTICALS INC.
Type
Standard
Approval Details
Approval Id
cb10717f21260705
Drug Approval Canada Name
ELYXYB
Product Name
ELYXYB
Status
Approved
Status Date
2025-04-09
Din
02556804
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:08.04.08
Atc Original
M01AH01 CELECOXIB
Atc Name
m 01 ah 01
Aig Number
0137043004
Company Name
SCILEX PHARMACEUTICALS INC.
Company Address
960 San Antonio Road, Suite 100, Palo Alto, California, United States
Company Detail Path
/organization/scilex-pharmaceuticals-inc-phoenix-arizona-united-states
Company Information
Pharmaceutical Company Name
SCILEX PHARMACEUTICALS INC.
Country Name
United States
Province Name
Arizona
City Name
phoenix,arizona,country_us
Address
3800 N Central Ave Ste 460
Active Ingredients
CELECOXIB
120 MG / 4.8 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
cb10717f21260705
Type
Standard
Back to Health Canada Approvals
ELYXYB - Health Canada Drug Approval Details